| 7645761 |
Indoline derivatives |
Andrew Fensome, Lori L. Miller, Reinhold H. W. Bender, Puwen Zhang, Jay E. Wrobel +4 more |
2010-01-12 |
|
| 7592363 |
Indazoles |
Robert J. Steffan, Edward Matelan, Stephen Bowen, Jay E. Wrobel, Edouard Zamaratski +7 more |
2009-09-22 |
$131,068,000 |
| 7576215 |
Quinolines and pharmaceutical compositions thereof |
Michael D. Collini, Robert R. Singhaus, Jr., Baihua Hu, James Jetter, Robert L. Morris +8 more |
2009-08-18 |
$124,238,000 |
| 7291646 |
Ethers of O-desmethyl venlafaxine |
John P. Yardley, Magid A. Abou-Gharbia |
2007-11-06 |
$45,032,000 |
| 7253203 |
Indoline derivatives |
Andrew Fensome, Lori L. Miller, Reinhold H. W. Bender, Puwen Zhang, Jay E. Wrobel +4 more |
2007-08-07 |
$92,830,000 |
| 7084168 |
Indoline derivatives |
Andrew Fensome, Lori L. Miller, Reinhold H. W. Bender, Puwen Zhang, Jay E. Wrobel +4 more |
2006-08-01 |
$126,540,000 |
| 7022733 |
Substituted 2-phenyl benzofurans as estrogenic agents |
Christopher Miller, Michael D. Collini, David Kaufman, Robert L. Morris, Robert R. Singhaus, Jr. +4 more |
2006-04-04 |
$39,675,000 |
| 6835744 |
3,3-substituted indoline derivatives |
Andrew Fensome, Jay E. Wrobel, Lin Zhi, Todd K. Jones, James P. Edwards +1 more |
2004-12-28 |
|
| 6774248 |
Substituted 2-phenyl benzofurans as estrogenic agents |
Christopher Miller, Michael D. Collini, David Kaufman, Robert L. Morris, Robert R. Singhaus, Jr. +4 more |
2004-08-10 |
$274,916,000 |
| 6608068 |
Indoline derivatives |
Andrew Fensome, Lori L. Miller, Reinhold H. W. Bender, Puwen Zhang, Jay E. Wrobel +4 more |
2003-08-19 |
|
| 6544970 |
Cyclic regimens utilizing indoline derivatives |
Gary S. Grubb, Andrew Fensome, Lori L. Miller, Reinhold H. W. Bender, Puwen Zhang +5 more |
2003-04-08 |
|
| 6503942 |
Ethers of O-Desmethyl venlafaxine |
John P. Yardley, Magid A. Abou-Gharbia |
2003-01-07 |
$140,984,000 |
| 6503939 |
Combination regimens using 3,3-substituted indoline derivatives |
Gary S. Grubb, Andrew Fensome, Jay E. Wrobel, James P. Edwards, Todd K. Jones +2 more |
2003-01-07 |
|
| 6462032 |
Cyclic regimens utilizing indoline derivatives |
Gary S. Grubb, Andrew Fensome, Lori L. Miller, Reinhold H. W. Bender, Puwen Zhang +5 more |
2002-10-08 |
|
| 6417214 |
3,3-substituted indoline derivatives |
Andrew Fensome, Jay E. Wrobel, Lin Zhi, Todd K. Jones, James P. Edwards +1 more |
2002-07-09 |
|
| 6391907 |
Indoline derivatives |
Andrew Fensome, Lori L. Miller, Reinhold H. W. Bender, Puwen Zhang, Jay E. Wrobel +4 more |
2002-05-21 |
|
| 6380185 |
N-substituted benzoyl indoles as estrogenic agents |
Marci C. Koko, Arthur A. Santilli |
2002-04-30 |
$119,158,000 |
| 6358943 |
N-substituted indolines as estrogenic agents |
— |
2002-03-19 |
$307,870,000 |
| 6348494 |
Ethers of o-desmethyl venlafaxine |
John P. Yardley, Magid A. Abou-Gharbia |
2002-02-19 |
$207,647,000 |
| 6329416 |
Combination regimens using 3,3-substituted indoline derivatives |
Gary S. Grubb, Andrew Fensome, Jay E. Wrobel, James P. Edwards, Todd K. Jones +2 more |
2001-12-11 |
|
| 6057369 |
Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
Robert D. Groneberg, Kent W. Neuenschwander, Stevan W. Djuric, Gerald M. McGeehan, Christopher J. Burns +4 more |
2000-05-02 |
|
| 5451596 |
Cycloalkyl amine bis-aryl squalene synthase inhibitors |
Terence John Kiesow, Kent W. Neuenschwander, Keith S. Learn, William P. Dankulich, Anthony C. Scotese |
1995-09-19 |
$17,117,000 |
| 5317015 |
Azacyclic bisphosphonates as anticholesterolemic agents |
Raymond D. Youssefyeh, Daniel L. Cheney, Christopher J. Burns |
1994-05-31 |
$23,851,000 |
| 5248830 |
Enantioselective preparation of acetylenic or olefinic substituted cycloalkenyl dihydroxybutyrates and 4-hydroxy-tetrahydro-pyran-2-ones |
John R. Regan |
1993-09-28 |
$26,943,000 |
| 4992429 |
Novel HMG-COA reductase inhibitors |
Kent W. Neuenschwander, John R. Regan |
1991-02-12 |
$8,819,000 |
